Plant-based nutrition supplements brand using proprietary nano-formulation technology.
| Date | Round | Amount |
|---|---|---|
| Feb 2026 | Funding round ZeroHarm Sciences raised ₹65 Cr (~$7.2M) co-led by Kotak Alternate Asset Managers and Alkemi Growth Capital for international expansion. | $7.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.